| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |